Literature DB >> 17513564

Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae.

Erwin Lamping1, Brian C Monk, Kyoko Niimi, Ann R Holmes, Sarah Tsao, Koichi Tanabe, Masakazu Niimi, Yoshimasa Uehara, Richard D Cannon.   

Abstract

The study of eukaryotic membrane proteins has been hampered by a paucity of systems that achieve consistent high-level functional protein expression. We report the use of a modified membrane protein hyperexpression system to characterize three classes of fungal membrane proteins (ABC transporters Pdr5p, CaCdr1p, CaCdr2p, CgCdr1p, CgPdh1p, CkAbc1p, and CneMdr1p, the major facilitator superfamily transporter CaMdr1p, and the cytochrome P450 enzyme CaErg11p) that contribute to the drug resistance phenotypes of five pathogenic fungi and to express human P glycoprotein (HsAbcb1p). The hyperexpression system consists of a set of plasmids that direct the stable integration of a single copy of the expression cassette at the chromosomal PDR5 locus of a modified host Saccharomyces cerevisiae strain, ADDelta. Overexpression of heterologous proteins at levels of up to 29% of plasma membrane protein was achieved. Membrane proteins were expressed with or without green fluorescent protein (GFP), monomeric red fluorescent protein, His, FLAG/His, Cys, or His/Cys tags. Most GFP-tagged proteins tested were correctly trafficked within the cell, and His-tagged proteins could be affinity purified. Kinetic analysis of ABC transporters indicated that the apparent K(m) value and the V(max) value of ATPase activities were not significantly affected by the addition of His tags. The efflux properties of seven fungal drug pumps were characterized by their substrate specificities and their unique patterns of inhibition by eight xenobiotics that chemosensitized S. cerevisiae strains overexpressing ABC drug pumps to fluconazole. The modified hyperexpression system has wide application for the study of eukaryotic membrane proteins and could also be used in the pharmaceutical industry for drug screening.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513564      PMCID: PMC1951111          DOI: 10.1128/EC.00091-07

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  64 in total

1.  A novel method of affinity-purifying proteins using a bis-arsenical fluorescein.

Authors:  K S Thorn; N Naber; M Matuska; R D Vale; R Cooke
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

2.  The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility.

Authors:  R Egner; B E Bauer; K Kuchler
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

3.  Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.

Authors:  Ann R Holmes; Sarah Tsao; Soo-Wee Ong; Erwin Lamping; Kyoko Niimi; Brian C Monk; Masakazu Niimi; Aki Kaneko; Barbara R Holland; Jan Schmid; Richard D Cannon
Journal:  Mol Microbiol       Date:  2006-08-30       Impact factor: 3.501

4.  Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants.

Authors:  J DeRisi; B van den Hazel; P Marc; E Balzi; P Brown; C Jacq; A Goffeau
Journal:  FEBS Lett       Date:  2000-03-24       Impact factor: 4.124

5.  Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.

Authors:  K Niimi; K Maki; F Ikeda; A R Holmes; E Lamping; M Niimi; B C Monk; R D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  A "silent" polymorphism in the MDR1 gene changes substrate specificity.

Authors:  Chava Kimchi-Sarfaty; Jung Mi Oh; In-Wha Kim; Zuben E Sauna; Anna Maria Calcagno; Suresh V Ambudkar; Michael M Gottesman
Journal:  Science       Date:  2006-12-21       Impact factor: 47.728

7.  Phenotypic effects of membrane protein overexpression in Saccharomyces cerevisiae.

Authors:  Marie Osterberg; Hyun Kim; Jonas Warringer; Karin Melén; Anders Blomberg; Gunnar von Heijne
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

8.  The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae.

Authors:  B Bonetti; L Fu; J Moon; D M Bedwell
Journal:  J Mol Biol       Date:  1995-08-18       Impact factor: 5.469

Review 9.  Multiple molecular mechanisms for multidrug resistance transporters.

Authors:  Christopher F Higgins
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

10.  Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay.

Authors:  Hotcherl Jeong; Ira Herskowitz; Deanna L Kroetz; Jasper Rine
Journal:  PLoS Genet       Date:  2007-03-09       Impact factor: 5.917

View more
  73 in total

1.  A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.

Authors:  Somanon Bhattacharya; Jack D Sobel; Theodore C White
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.

Authors:  Brian C Monk; Mikhail V Keniya; Manya Sabherwal; Rajni K Wilson; Danyon O Graham; Harith F Hassan; Danni Chen; Joel D A Tyndall
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2.

Authors:  Sanjiveeni Dhamgaye; Frederic Devaux; Raman Manoharlal; Patrick Vandeputte; Abdul Haseeb Shah; Ashutosh Singh; Corinne Blugeon; Dominique Sanglard; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

Review 4.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

5.  Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.

Authors:  Luiz R Basso; Charles E Gast; Yuxin Mao; Brian Wong
Journal:  Eukaryot Cell       Date:  2010-03-26

Review 6.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

7.  Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.

Authors:  Luiz R Basso; Charles E Gast; Igor Bruzual; Brian Wong
Journal:  J Antimicrob Chemother       Date:  2015-01-27       Impact factor: 5.790

8.  Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.

Authors:  Sarah Tsao; Sandra Weber; Christine Cameron; Dominic Nehme; Elaheh Ahmadzadeh; Martine Raymond
Journal:  J Antimicrob Chemother       Date:  2016-07-07       Impact factor: 5.790

Review 9.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

10.  Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.

Authors:  Edward Sionov; Hyeseung Lee; Yun C Chang; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.